Metformin as target metabolic drug in oncology
نویسندگان
چکیده
منابع مشابه
P14: Mitochondria as a Target for Drug Therapy in Epilepsy
لطفاً به چکیده انگلیسی مراجعه شود.
متن کاملMetformin as a Tool to Target Aging.
Aging has been targeted by genetic and dietary manipulation and by drugs in order to increase lifespan and health span in numerous models. Metformin, which has demonstrated protective effects against several age-related diseases in humans, will be tested in the TAME (Targeting Aging with Metformin) trial, as the initial step in the development of increasingly effective next-generation drugs.
متن کاملIntrinsic Protein Disorder as a Drug Target in Oncology: Designing Drugs Targeting Plasticity
Cancer is gradually becoming the leading disease-related cause of death of the human population. Thus, there is an ultimate need for innovation in drug discovery and development, especially in the area of oncology. Unfortunately, clinical attrition rates are a critical issue in drug development, particularly in oncology where over fourfold higher rates of attrition were determined in respect to...
متن کاملMetformin: its emerging role in oncology.
Metformin is considered, in conjunction with lifestyle modification, as a first-line treatment modality for type 2 diabetes mellitus (DM). Recently, several clinical studies have reported reduced incidence of neoplastic diseases in DM type 2 patients treated with metformin, as compared to diet or other antidiabetic agents. Moreover, in vitro studies have disclosed significant antiproliferative ...
متن کاملPyruvate dehydrogenase kinase as a novel therapeutic target in oncology
Current drug development in oncology is non-selective as it typically focuses on pathways essential for the survival of all dividing cells. The unique metabolic profile of cancer, which is characterized by increased glycolysis and suppressed mitochondrial glucose oxidation (GO) provides cancer cells with a proliferative advantage, conducive with apoptosis resistance and even increased angiogene...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Malignant tumours
سال: 2017
ISSN: 2224-5057
DOI: 10.18027/2224-5057-2017-2-83-89